A Multiple Dose Study Of PF-04620110 In Type 2 Diabetes Patients

NCT01298518 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Patients

Interventions

DRUG: PF-04620110
DRUG: PF-04620110
DRUG: Placebo

Sponsor

Pfizer